A promising study on preventing metastatic breast cancer has been paused due to a federal stop-work order, according to Weill Cornell Medicine. Dr. Nancy Du, who has spent over two decades researching cancer spread, had just begun testing a hypothesis on treatment resistance when her Department of Defense-funded project was halted.
Du’s lab was investigating why cancer cells become unresponsive to endocrine therapy and how to stop them from spreading to bones. Her work had already shed light on why some experimental drugs fail and was on track for clinical testing.
She says losing momentum now risks wasting critical discoveries and prolonging suffering for patients like her late father, who endured toxic treatments without lasting results.